| Serial Number | 97470141 |
| Word Mark | UBIP |
| Filing Date | Wednesday, June 22, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 25, 2025 |
| Registration Number | 7739637 |
| Registration Date | Tuesday, March 25, 2025 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 18, 2023 |
| Description of Mark | The mark consists of the stylized letters "UBIP." A stylized globe forms a portion of the letter "P" in "UBIP". |
| Goods and Services | Antibiotics; Pre-filled syringes for medical purposes being syringes sold filled with pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Medicines for human purposes for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Contrast medium for medical use being contrast media for in vivo imaging; Ointments for pharmaceutical purposes being anti-biotic, anti-infective, and anti-inflammatory ointments; Poultices for pharmaceutical purposes being anti-biotic, anti-infective, and anti-inflammatory poultices; Western medicine, namely, pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Active pharmaceutical ingredients (APIs) for Western Medicine being pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Vitamin preparations; antiviral drug; biological preparations for medical purposes being biological preparations for the treatment of cancers, infections, metabolic diseases, neurological disorders; Hormones for medical purposes; Medicated skin lotions for pharmaceutical purposes; Medicinal drinks; Vaccines; chemico-pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, neurological disorders; Albuminous preparations for medical purposes, namely, pharmaceutical preparations featuring albumin peptides, proteins and complexes thereof for the treatment of cancers, infections, metabolic diseases, and neurological disorders; biological reagent for medical purposes; test reagent for medical purposes; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Providing research and development in the field of biological and pharmaceutical scientific research and development; Biological research; Bacteriological research; Clinical lab test of medical reagent being providing reagent sample testing for others for scientific research purposes; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Research and analysis of medical reagent being medical research; medical research; Research and development of new products for others; Technical project studies being conducting of feasibility studies in the field of new technologies; Technical writing; Industrial analysis and research service in the field of pharmaceutical sciences; Rental of laboratory instruments; Scientific laboratory services; Technological consultancy in the field of biological and pharmaceutical manufacturing processes; scientific research and technological research in the field of biological and pharmaceutical manufacturing processes; culturing of cells for others for scientific research purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 8, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, October 31, 2022 |
| First Use In Commerce Date | Monday, October 31, 2022 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 8, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, October 31, 2022 |
| First Use In Commerce Date | Monday, October 31, 2022 |
| Party Name | UBI Pharma Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Hsinchu County 30351 TW |
| Party Name | UBI Pharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Hsinchu County 30351 TW |
| Party Name | UBI Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Hsinchu County 30351 TW |
| Event Date | Event Description |
| Tuesday, April 11, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, June 25, 2022 | NEW APPLICATION ENTERED |
| Monday, July 11, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 12, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, April 4, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, April 11, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 9, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 8, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, June 8, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 8, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 8, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, June 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 28, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 18, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 18, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 12, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, October 23, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, February 20, 2024 | USE AMENDMENT FILED |
| Tuesday, February 20, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Monday, March 11, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Saturday, March 16, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, April 12, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Friday, April 12, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, April 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 11, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 22, 2024 | ASSIGNED TO LIE |
| Friday, November 15, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, November 15, 2024 | SU - FINAL REFUSAL - WRITTEN |
| Friday, February 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 14, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, November 15, 2024 | FINAL REFUSAL E-MAILED |
| Friday, February 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 3, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, March 25, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 25, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Monday, March 3, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |